Literature DB >> 23859613

Glutamine, glucose and other fuels for cancer.

Maria Victoria Ruiz-Perez, Francisca Sanchez-Jimenez, Francisco J Alonso, Juan A Segura, Javier Marquez, Miguel Angel Medina1.   

Abstract

Tumor cells suffer a metabolic reprogramming which allows them to use metabolic fuels (glucose, glutamine, lipids) through anabolic fates to support their enhanced proliferation and other carcinogenesis-related features. The present review tries to address and summarize the broad and growing information available about this reprogramming, whose pieces, put together, make up a complex scheme that encompasses different complexity scales, from cells to systemic networks.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23859613     DOI: 10.2174/13816128113199990482

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  15 in total

Review 1.  Polyamines in mammalian pathophysiology.

Authors:  Francisca Sánchez-Jiménez; Miguel Ángel Medina; Lorena Villalobos-Rueda; José Luis Urdiales
Journal:  Cell Mol Life Sci       Date:  2019-06-21       Impact factor: 9.261

Review 2.  Metabolic restructuring and cell fate conversion.

Authors:  Alessandro Prigione; María Victoria Ruiz-Pérez; Raul Bukowiecki; James Adjaye
Journal:  Cell Mol Life Sci       Date:  2015-01-14       Impact factor: 9.261

3.  Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma.

Authors:  Edward Sanders; Svenja Diehl
Journal:  Oncoscience       Date:  2015-02-17

4.  Bioinformatics analysis of the serine and glycine pathway in cancer cells.

Authors:  Alexey Antonov; Massimiliano Agostini; Maria Morello; Marilena Minieri; Gerry Melino; Ivano Amelio
Journal:  Oncotarget       Date:  2014-11-30

5.  Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis.

Authors:  Kuang-Ming Liao; Tung-Bo Chao; Yu-Feng Tian; Ching-Yih Lin; Sung-Wei Lee; Hua-Ying Chuang; Ti-Chun Chan; Tzu-Ju Chen; Chung-Hsi Hsing; Ming-Jen Sheu; Chien-Feng Li
Journal:  J Cancer       Date:  2016-05-25       Impact factor: 4.207

Review 6.  ROS homeostasis and metabolism: a dangerous liason in cancer cells.

Authors:  E Panieri; M M Santoro
Journal:  Cell Death Dis       Date:  2016-06-09       Impact factor: 8.469

Review 7.  The MYCN Protein in Health and Disease.

Authors:  María Victoria Ruiz-Pérez; Aine Brigette Henley; Marie Arsenian-Henriksson
Journal:  Genes (Basel)       Date:  2017-03-30       Impact factor: 4.096

8.  Circ_0137287 suppresses cell tumroigenesis and aerobic glycolysis in papillary thyroid carcinoma through miR-183-5p/PPP2R2A axis.

Authors:  Jingjing Ma; Zhenghua Kan
Journal:  Cytotechnology       Date:  2021-05-13       Impact factor: 2.040

9.  CircPUM1 promotes cell growth and glycolysis in NSCLC via up-regulating METTL3 expression through miR-590-5p.

Authors:  Mingjun Li; Qianqian Wang; Xiaofei Zhang; Ningning Yan; Xingya Li
Journal:  Cell Cycle       Date:  2021-06-07       Impact factor: 5.173

10.  Methionine-restricted diet inhibits growth of MCF10AT1-derived mammary tumors by increasing cell cycle inhibitors in athymic nude mice.

Authors:  J R Hens; I Sinha; F Perodin; T Cooper; R Sinha; J Plummer; C E Perrone; D Orentreich
Journal:  BMC Cancer       Date:  2016-06-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.